Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 16676-29-2 | Product Number: N1176
Naltrexone Hydrochloride
Purity: >98.0%(GC)(HPLC)
- Trexan
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | N1176 |
Purity / Analysis Method
|
>98.0%(GC)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__0H__2__3NO__4·HCl = 377.87 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Hygroscopic,Heat Sensitive |
Packaging and Container
|
1G-Glass Bottle with Plastic Insert (View image), 250MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 16676-29-2 |
| Reaxys Registry Number | 3580333 |
| PubChem Substance ID | 468592499 |
| MDL Number | MFCD00069324 |
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Water | max. 11.0 % |
| Melting Point | 178 °C |
| Solubility in water | Soluble |
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
| EC Number | 240-723-0 |
| RTECS# | QD2160000 |
| HS Number | 2939190000 |
References
- 1) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog
- 2) Alteration of ethanol self-administration by naltrexone
- 3) Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence (a review)
- 4) The opioid growth factor-opioid growth factor receptor axis: Homeostatic regulator of cell proliferation and its implications for health and disease (a review)
- 5) Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy (a review)
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.